| NCT ID | NCT06782321 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-05-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate whether adding an emotional wellness component to occupational therapy (OT) and/or speech therapy (ST) telerehabilitation improves overall emotional well-being and activity participation for people with stroke.
Eligibility Criteria
Inclusion Criteria: * Self-reported stroke-related deficits in emotional wellness such as anxiety, sleep disturbance, dread, fear, loss of hope, sadness. * Have experienced ischemic or hemorrhagic stroke at least 30 days prior * Stroke-related aphasia and/or upper extremity hemiparesis * Aged 21 years or older * English as primary language * Have corrected vision to be able to read text on a screen * Able to participate fully in the study's tele-rehabilitation (Aim 1) and/or virtual group programing (Aim 2) with personally owned device (i.e., phone, tablet, or laptop) and personal Wi-Fi connection or cellular service * Cognitive, language, and motor capacity to participate fully in the study's assessment session as per the judgment of the licensed, experienced stroke tele-rehabilitation occupational or speech therapist Exclusion Criteria: * Unable to follow 1-2 step instructions given by the study team member during the informed consent procedures. * Pain that interferes with ability to participate in the study's upper extremity movement tasks. * Have impaired decision making capacity as determined by the U-ARE protocol for assessing capacity to provide informed consent.
Contact & Investigator
Michelle Woodbury, PhD
PRINCIPAL INVESTIGATOR
Medical University of South Carolina
Frequently Asked Questions
Who can join the NCT06782321 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06782321 currently recruiting?
Yes, NCT06782321 is actively recruiting participants. Contact the research team at piersonp@musc.edu for enrollment information.
Where is the NCT06782321 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT06782321 clinical trial?
NCT06782321 is sponsored by Medical University of South Carolina. The principal investigator is Michelle Woodbury, PhD at Medical University of South Carolina. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.